Expression and location of pro-apoptotic bcl-2 family protein BAD in normal human tissues and tumor cell lines

American Journal of Pathology

Volumn 152, Issue 1, 1998, Pages 51-61

  Kitada, Shinichi ^a   Krajewska, Maryla ^a   Zhang, Xin ^a   Scudiero, Dominic ^c   Zapata, Juan M ^a   Wang, Hong Gang ^a   Shabaik, Ahmed ^b   Tudor, Gabriella ^c   Krajewski, Stanislaw ^a   Myers, Timothy G ^d   Johnson, George S ^d   Sausville, Edward A ^d   Reed, John C ^a  

^a BURNHAM INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN BCL 2;

ARTICLE; CELL DEATH; CELL ORGANELLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSOL; DIMERIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; TISSUE DISTRIBUTION; TUMOR CELL LINE;

ANTIBODIES, MONOCLONAL; APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; CARRIER PROTEINS; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; PROTO-ONCOGENE PROTEINS C-BCL-2; REFERENCE VALUES; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED;

EID: 0031974526     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994, 124: 1-6
2. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 1995, 267: 1456-1462
3. Ruoslahti E, Reed JC: Anchorage dependence, integrins, and apoptosis. Cell 1994, 77: 477-478
4. Yang E, Korsmeyer SJ: Molecular thanatopsis: a discourse on the Bcl2 family and cell death. Blood 1996, 88: 386-401
5. Yang E, Jockel J, Zha J, Korsmeyer S: Bad, a new bcl-2 family member, heterodimerizes with bcl-2 and bcl-XL in vivo and promotes cell death. Blood 1994, 84(suppl 1): 373a
6. Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ: Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces bax and promotes cell death. Cell 1995, 80: 285-291
7. L. Cell 1996, 87: 619-628
8. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME: Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997, 91: 231-241
9. Wang HG, Rapp UR, Reed JC: Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell 1996, 87: 629-638
10. Katsumata M, Siegel RM, Louie DC, Miyashita T, Tsujimoto Y, Nowell PC, Greene MI, Reed JC: Differential effects of Bcl-2 on T and B cells in transgenic mice. Proc Natl Acad Sci USA 1992, 89: 11376-11380
11. Reed JC, Tanaka S, Cuddy M, Cho D, Smith J, Kallen R, Saragovi HU, Torigoe T: A strategy for generating monoclonal antibodies against recombinant baculovirus-produced proteins: application to the Bcl-2 oncoprotein. Anal Biochem 1992, 205: 70-76
12. Krajewski S, Krajewska M, Shabaik A, Wang H-G, Irie S, Fong L, Reed JC: Immunohistochemical analysis of in vivo patterns of Bcl-X expression. Cancer Res 1994, 54: 5501-5507
13. Krajewski S, Bodrug S, Krajewska M, Shabaik A, Gascoyne R, Berean K, Reed JC: Immunohistochemical analysis of Mcl-1 protein in human tissues: differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivo. Am J Pathol 1995, 146: 1309-1319
14. Krajewski S, Krajewska M, Reed JC: Immunohistochemical analysis of in vivo patterns of Bak expression, a pro-apoptotic member of the Bcl-2 protein family. Cancer Res 1996, 56: 2849-2855
15. Lee JS, Paull K, Alvarez M, Hose C, Monks A, Grever M, Fojo AT, Bates SE: Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen. Mol Pharmacol 1994, 46: 627-638